YU201987A - Process for obtaining dihydropyridine - Google Patents

Process for obtaining dihydropyridine

Info

Publication number
YU201987A
YU201987A YU02019/87A YU201987A YU201987A YU 201987 A YU201987 A YU 201987A YU 02019/87 A YU02019/87 A YU 02019/87A YU 201987 A YU201987 A YU 201987A YU 201987 A YU201987 A YU 201987A
Authority
YU
Yugoslavia
Prior art keywords
dihydropyridine
obtaining
obtaining dihydropyridine
Prior art date
Application number
YU02019/87A
Other languages
English (en)
Inventor
K Cooper
P E Cross
F M Jonathan
M J Fray
K Richardson
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626698A external-priority patent/GB8626698D0/en
Priority claimed from GB878709842A external-priority patent/GB8709842D0/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of YU201987A publication Critical patent/YU201987A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
YU02019/87A 1986-11-07 1987-11-06 Process for obtaining dihydropyridine YU201987A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626698A GB8626698D0 (en) 1986-11-07 1986-11-07 Therapeutic agents
GB878709842A GB8709842D0 (en) 1987-04-25 1987-04-25 Therapeutic agents

Publications (1)

Publication Number Publication Date
YU201987A true YU201987A (en) 1988-12-31

Family

ID=26291518

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02019/87A YU201987A (en) 1986-11-07 1987-11-06 Process for obtaining dihydropyridine

Country Status (17)

Country Link
US (1) US4801598A (de)
EP (1) EP0266989B1 (de)
JP (1) JPH064624B2 (de)
KR (1) KR880006196A (de)
CN (1) CN87107723A (de)
AU (1) AU8089687A (de)
DE (1) DE3763573D1 (de)
DK (1) DK582787A (de)
ES (1) ES2036214T3 (de)
FI (1) FI874866A (de)
GR (2) GR880300183T1 (de)
HU (1) HUT45990A (de)
IL (1) IL84380A0 (de)
NO (1) NO874194L (de)
PL (1) PL268618A1 (de)
PT (1) PT86082B (de)
YU (1) YU201987A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8712747D0 (en) * 1987-05-30 1987-07-01 Pfizer Ltd Therapeutic agents
GB8716971D0 (en) * 1987-07-17 1987-08-26 Pfizer Ltd Therapeutic agents
MY104933A (en) 1987-09-30 1994-07-30 Pfizer Ltd Platelet activating factor antagonists
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8906324D0 (en) * 1989-03-20 1989-05-04 Pfizer Ltd 1,4-dihydropyridines
DE4237617A1 (de) * 1992-11-06 1994-05-11 Bayer Ag Verwendung von substituierten Benzimidazolen
US5496855A (en) * 1995-01-27 1996-03-05 Smithkline Beecham Corp. Anti-inflammatory compounds
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US6566359B1 (en) 2002-05-20 2003-05-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College 2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid esters as neuroprotective drugs
EP2392258B1 (de) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-Informatiksystem
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
JP7148192B1 (ja) 2022-05-09 2022-10-05 有限会社Amplus 表示制御装置および方法並びにプログラム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
NL8503262A (nl) * 1984-12-10 1986-07-01 Sandoz Ag 1,4-dihydropyridinederivaten, werkwijze voor het bereiden van deze derivaten en farmaceutische preparaten die ze bevatten.
HU199796B (en) * 1985-08-06 1990-03-28 Boehringer Biochemia Srl Process for producing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions comprising such compounds
EP0225175A3 (de) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
GR3000820T3 (en) 1991-11-15
KR880006196A (ko) 1988-07-22
EP0266989B1 (de) 1990-07-04
FI874866A (fi) 1988-05-08
PT86082B (pt) 1990-11-20
JPS63139167A (ja) 1988-06-10
IL84380A0 (en) 1988-04-29
JPH064624B2 (ja) 1994-01-19
ES2036214T3 (es) 1993-05-16
NO874194L (no) 1988-05-09
HUT45990A (en) 1988-09-28
NO874194D0 (no) 1987-10-06
PL268618A1 (en) 1988-09-01
CN87107723A (zh) 1988-05-18
DK582787A (da) 1988-05-08
EP0266989A2 (de) 1988-05-11
US4801598A (en) 1989-01-31
PT86082A (en) 1987-12-01
FI874866A0 (fi) 1987-11-04
DE3763573D1 (de) 1990-08-09
GR880300183T1 (en) 1989-06-22
EP0266989A3 (en) 1988-09-28
AU8089687A (en) 1988-05-12
DK582787D0 (da) 1987-11-06

Similar Documents

Publication Publication Date Title
EG18230A (en) Process for preparing 3-aryloxy-3-substituted propanamines
YU34587A (en) Process for preparing purinic nucleozides
YU131088A (en) Process for obtaining 1-terciaric-alkyl-substituted naphtiridine- and hynolin-carboxylic intermediers
YU73987A (en) Process for obtaining hynoline derivatives
ZA876516B (en) Process for preparing 3-pyrrolidinols
YU201987A (en) Process for obtaining dihydropyridine
EP0245960A3 (en) Process for preparing n-acyltetrahydroisoquinoline
YU201887A (en) Process for obtaining eritro-/treo-methyl-4-ciano-3-(p-fluorphenyl)-4-(m-fluorphenyl) butirate
GB8613354D0 (en) Process
GB8616037D0 (en) Process
YU105287A (en) Process for obtaining specific 3-benzole-4-oxolactame
YU105387A (en) Process for obtaining some substituted-3-amino-2-benzoilcyclohex-2-nones
YU119887A (en) Process for preparing dihydroizoquinolines
GB8604440D0 (en) Process
YU47287A (en) Process for making alkylsulphonylalkylchlorobenzole
YU118187A (en) Process for obtaining mercaptoacylproline
PT86424A (en) Process for preparing substituted tetrahydropyridoindoles
YU179288A (en) Process for obtaining anilynoforumates
PT84383A (en) Process for preparing substituted pyrimidoindoles
GB8603768D0 (en) Process
GB2191929B (en) Process for making sour-and-hot-bread
CS331887A2 (en) Process for preparing tetrahydrotetramethylnaphthylpropenylphenoles
GB8603766D0 (en) Process
RO93530B1 (ro) Procedeu de obtinere a antocianilor
YU142288A (en) Process for preparing tetrahydro-benzothiazolo-quinolines